Literature DB >> 10497994

Long-term suppression of adult bladder morbidity and severe hydronephrosis following selective population chemotherapy for Schistosoma haematobium.

A K Subramanian1, P Mungai, J H Ouma, P Magak, C H King, A A Mahmoud, C L King.   

Abstract

Repeated selective population chemotherapy of school age children reduces infection and morbidity associated with Schistosoma haematobium infection. To examine the long-term effect of this treatment on susceptibility to re-infection and late disease, a cohort of Kenyans (n = 194) were re-examined for infection and urinary tract morbidity 7-13 years after they underwent annual ultrasonography and treatment for an average of 5 years beginning in 1984 as children. Controls were previously untreated age-matched individuals residing in the same or adjacent villages. The overall prevalence and intensity of infection were equivalent between the 2 groups. In contrast, the prevalence of bladder wall pathology was 11-fold lower in previously treated (1.5%) versus untreated subjects (17%). Severe hydronephrosis was completely reversed. These data demonstrate that treatment significantly reduced urinary tract morbidity despite re-infection, and suggest that the important risk factors for urinary tract morbidity in adulthood are cumulative intensity and duration of infection during early adolescence.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10497994     DOI: 10.4269/ajtmh.1999.61.476

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  8 in total

Review 1.  Schistosomiasis--an unusual cause of ureteral obstruction: a case history and perspective.

Authors:  Peter M Neal
Journal:  Clin Med Res       Date:  2004-11

2.  Cytokine control of the granulomatous response in Schistosoma mansoni-infected baboons: role of exposure and treatment.

Authors:  P W Mola; I O Farah; T M Kariuki; M Nyindo; R E Blanton; C L King
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

Review 3.  Examining the relationship between urogenital schistosomiasis and HIV infection.

Authors:  Pamela Sabina Mbabazi; Olivia Andan; Daniel W Fitzgerald; Lester Chitsulo; Dirk Engels; Jennifer A Downs
Journal:  PLoS Negl Trop Dis       Date:  2011-12-06

4.  The colposcopic atlas of schistosomiasis in the lower female genital tract based on studies in Malawi, Zimbabwe, Madagascar and South Africa.

Authors:  Hanne M Norseth; Patricia D Ndhlovu; Elisabeth Kleppa; Bodo S Randrianasolo; Peter M Jourdan; Borghild Roald; Sigve D Holmen; Svein G Gundersen; Jayanthilall Bagratee; Mathias Onsrud; Eyrun F Kjetland
Journal:  PLoS Negl Trop Dis       Date:  2014-11-20

5.  A comparison of urinary tract pathology and morbidity in adult populations from endemic and non-endemic zones for urinary schistosomiasis on Unguja Island, Zanzibar.

Authors:  Beatrice Lyons; Russel Stothard; David Rollinson; Simba Khamis; Khamis A Simai; Paul R Hunter
Journal:  BMC Infect Dis       Date:  2009-11-29       Impact factor: 3.090

6.  Urogenital schistosomiasis infection prevalence targets to determine elimination as a public health problem based on microhematuria prevalence in school-age children.

Authors:  Ryan E Wiegand; Fiona M Fleming; Anne Straily; Susan P Montgomery; Sake J de Vlas; Jürg Utzinger; Penelope Vounatsou; W Evan Secor
Journal:  PLoS Negl Trop Dis       Date:  2021-06-11

7.  Potential cost-effectiveness of schistosomiasis treatment for reducing HIV transmission in Africa--the case of Zimbabwean women.

Authors:  Martial L Ndeffo Mbah; Eric M Poolman; Katherine E Atkins; Evan W Orenstein; Lauren Ancel Meyers; Jeffrey P Townsend; Alison P Galvani
Journal:  PLoS Negl Trop Dis       Date:  2013-08-01

8.  Dynamics of paediatric urogenital schistosome infection, morbidity and treatment: a longitudinal study among preschool children in Zimbabwe.

Authors:  Derick Nii Mensah Osakunor; Takafira Mduluza; Nicholas Midzi; Margo Chase-Topping; Masceline Jenipher Mutsaka-Makuvaza; Theresa Chimponda; Enwono Eyoh; Tariro Mduluza; Lorraine Tsitsi Pfavayi; Welcome Mkululi Wami; Seth Appiah Amanfo; Janice Murray; Clement Tshuma; Mark Edward John Woolhouse; Francisca Mutapi
Journal:  BMJ Glob Health       Date:  2018-03-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.